CANDRIAM S.C.A. – Vertex Pharmaceuticals Incorporated Transaction History
CANDRIAM S.C.A. portfolio value:
$140.30M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.56% | 16.65K shares | 8.46M | $289.54 | 484.53K |
| Q2 2022 | share | Decrease | -1.34% | -6.37K shares | 8.07M | $281.79 | 467.88K |
| Q1 2022 | share | Decrease | -26.43% | -170.37K shares | -17.80M | $260.97 | 474.25K |
| Q4 2021 | share | Increase | +8.74% | 51.80K shares | 34.03M | $222.45 | 644.63K |
| Q3 2021 | share | Decrease | -26.62% | -215.03K shares | -55.36M | $181.39 | 592.82K |
| Q2 2021 | share | Increase | +3.63% | 28.32K shares | -14.08M | $201.63 | 807.86K |
| Q1 2021 | share | Increase | 0.00% | 7 shares | -7.27M | $214.89 | 779.54K |
| Q4 2020 | share | Increase | +39.67% | 221.40K shares | 32.37M | $236.34 | 779.53K |
| Q3 2020 | share | Increase | +2.19% | 11.94K shares | -6.7M | $272.12 | 558.13K |
| Q2 2020 | share | Decrease | -24.70% | -179.17K shares | 3.32M | $290.31 | 546.19K |
| Q1 2020 | share | 0.00% | 0 shares | -3.56M | $237.95 | 725.36K | |
| Q4 2019 | share | Decrease | -22.09% | -205.63K shares | 1.08M | $218.95 | 725.36K |
| Q3 2019 | share | Decrease | -1.01% | -9.50K shares | -13.98M | $169.42 | 930.99K |
| Q2 2019 | share | Increase | +42.17% | 278.98K shares | 50.02M | $183.38 | 940.50K |
| Q1 2019 | share | Increase | +4.11% | 26.13K shares | 16.40M | $183.95 | 661.52K |
| Q4 2018 | share | Increase | +38.68% | 177.23K shares | 16.98M | $165.71 | 635.38K |
| Q3 2018 | share | Increase | +40.19% | 131.34K shares | 32.75M | $192.74 | 458.15K |
| Q2 2018 | share | Increase | +7.69% | 23.33K shares | 6.08M | $169.96 | 326.80K |
| Q1 2018 | share | Decrease | -14.70% | -52.30K shares | -3.85M | $162.98 | 303.47K |
| Q4 2017 | share | Decrease | -0.86% | -3.08K shares | -1.24M | $149.86 | 355.77K |
| Q3 2017 | share | Increase | +31.25% | 85.44K shares | 19.32M | $152.04 | 358.86K |
| Q2 2017 | share | Increase | +17.57% | 40.85K shares | 9.80M | $128.87 | 273.42K |
| Q1 2017 | share | Decrease | -9.65% | -24.85K shares | 6.46M | $109.35 | 232.56K |
| Q4 2016 | share | Increase | +25.29% | 51.96K shares | 1.04M | $73.67 | 257.41K |
| Q3 2016 | share | Increase | +40.50% | 59.22K shares | 5.33M | $87.21 | 205.45K |
| Q2 2016 | share | Decrease | -7.17% | -11.28K shares | 125K | $86.02 | 146.23K |
| Q1 2016 | share | Decrease | -35.22% | -85.64K shares | -18.14M | $79.49 | 157.51K |